December 16, 2013
Nagoya University Vice President Ryoichi Fujii Nagoya University denied in its interim report released on December 13 that clinical data on Novartis Pharma’s hypertension drug Diovan (valsartan) were manipulated. The university said that the data “were not intentionally manipulated,” even...read more